CN Patent
CN111285760B — 一种贝派地酸的合成方法及中间体
Assigned to Nanjing Baimai Biotechnology Co ltd · Expires 2020-08-25 · 6y expired
What this patent protects
本发明公开了一种贝派地酸的合成方法,以3‑溴‑2,2‑二甲基丙酸甲酯为原料,经与双联片哪醇硼酸酯反应,生成中间体化合物I,再与5‑酮‑1,9‑二溴壬烷反应,生成中间体化合物II,再经由水解,还原生成贝派地酸。
USPTO Abstract
本发明公开了一种贝派地酸的合成方法,以3‑溴‑2,2‑二甲基丙酸甲酯为原料,经与双联片哪醇硼酸酯反应,生成中间体化合物I,再与5‑酮‑1,9‑二溴壬烷反应,生成中间体化合物II,再经由水解,还原生成贝派地酸。
Drugs covered by this patent
- Nexletol (BEMPEDOIC ACID) · Esperion Theraps Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.